Search results for "Phospholipase A2"

showing 10 items of 70 documents

Dysidotronic acid, a new and selective human phospholipase A2 inhibitor from the sponge Dysidea sp.

2000

Abstract A new bioactive sesquiterpenoid, named dysidotronic acid 1, with a rearranged drimane skeleton has been isolated from the sponge Dysidea sp. from Vanuatu islands, along with bolinaquinone 2. The chemical structure of 1 was determined on the basis of spectroscopic data. Dysidotronic acid significantly inhibited human synovial phospholipase A2 (PLA2) at 10 μM, with an IC50 value of 2.6 μM and a higher selectivity and potency towards this enzyme than the reference inhibitor manoalide.

chemistry.chemical_classificationbiologyStereochemistryChemical structureOrganic Chemistrybiology.organism_classificationBiochemistrySpongeManoalidechemistry.chemical_compoundEnzymePhospholipase A2chemistryBiochemistryDrug Discoverybiology.proteinPotencySelectivityIC50Tetrahedron Letters
researchProduct

Morelloflavone, a novel biflavonoid inhibitor of human secretory phospholipase A2 with anti-inflammatory activity

1997

Abstract The flavanonylflavone morelloflavone inhibited secretory phospholipase A 2 (PLA 2 ) in vitro , with a high potency on the human recombinant synovial and bee venom enzymes ( IC 50 = 0.9 and 0.6 μM, respectively). The inhibition was apparently irreversible. In contrast, the compound was inactive on cytosolic PLA 2 activity from human monocytes. Morelloflavone scavenged reactive oxygen species generated by human neutrophils ( IC 50 = 2.7 and 1.8 μM for luminol and lucigenin, respectively) but did not modify cellular responses such as degranulation or eicosanoid release. This biflavonoid exerted anti-inflammatory effects in animal models, with a potent inhibition of 12-O-tetradecanoylp…

medicine.drug_classAnti-Inflammatory AgentsPharmacologyBiochemistryPhospholipases AAnti-inflammatoryMicePhospholipase A2medicineAnimalsBiflavonoidsHumansEnzyme InhibitorsFlavonoidsPharmacologychemistry.chemical_classificationPhospholipase ADose-Response Relationship DrugbiologyChemistryDegranulationBiological activityBiflavonoidPhospholipases A2EicosanoidBiochemistryMyeloperoxidaseLuminescent Measurementsbiology.proteinFemaleBiochemical Pharmacology
researchProduct

Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus

2000

The activity of the Santolina chamaecyparissus methanol extract was tested against the phospholipase A2 (PLA2)-induced mouse paw edema and in vitro inhibition of PLA2 activity. After fractionation, only the dichloromethane extract was active against the PLA2 in vitro test. In addition, it reduced the edema induced by arachidonic acid, and by 12-O-tetradecanoylphorbol-13-acetate in a multidose test. After chromatography on silicagel and gel filtration on Sephadex, and using an in vitro anti-PLA2 assay-guided process, we have isolated and identified from the dichloromethane extract the flavone nepetin and four sesquiterpenes.

medicine.drug_classAsteraceaePharmacologyFlavonesPhospholipases AGeneral Biochemistry Genetics and Molecular BiologyAnti-inflammatorySantolina chamaecyparissusMicechemistry.chemical_compoundPhospholipase A2medicineAnimalsEnzyme InhibitorsGeneral Pharmacology Toxicology and PharmaceuticsFlavonoidschemistry.chemical_classificationPlants MedicinalbiologyPlant ExtractsChemistryAnti-Inflammatory Agents Non-SteroidalGeneral Medicinebiology.organism_classificationIn vitroPhospholipases A2BiochemistrySephadexbiology.proteinFemalelipids (amino acids peptides and proteins)Arachidonic acidSesquiterpenesNepetinLife Sciences
researchProduct

Anti-inflammatory activity of two cucurbitacins isolated from Cayaponia tayuya roots.

2004

Fractionation of an anti-inflammatory extract from Cayaponia tayuya roots yielded two active compounds, identified as 23,24-dihydrocucurbitacin B (1) and cucurbitacin R (2). Both were evaluated for their anti-inflammatory activity on several experimental models of pain and inflammation. In addition, their cytotoxicity and effects on leukotriene B 4 (LTB 4 ) formation were evaluated in rat polymorphonuclear leukocytes. Both compounds showed activity in the following models: carrageenan-induced mouse paw oedema (1, 4 mg/kg p.o., 46% inhibition at 3 h), phospholipase A 2 -induced mouse paw oedema (2, 3 mg/kg i.p., 61% inhibition at 60 min), serotonin-induced mouse paw oedema (1 and 2, 0.5 mg/k…

medicine.drug_classLeukotriene B4Pharmaceutical ScienceAdministration OralPainPharmacologyAdministration CutaneousCarrageenanLeukotriene B4Plant RootsAnti-inflammatoryPhospholipases AAnalytical Chemistrychemistry.chemical_compoundMicePhospholipase A2Drug DiscoverymedicineLeukocytesAnimalsEdemaRats WistarPharmacologyPhospholipase AbiologyDose-Response Relationship DrugPlant ExtractsAntiglucocorticoidOrganic ChemistryAnti-Inflammatory Agents Non-SteroidalCucurbitacinsbiology.organism_classificationCayaponia tayuyaTriterpenesCarrageenanRatsCucurbitaceaePhospholipases A2Complementary and alternative medicinechemistryBiochemistryEicosanoidbiology.proteinMolecular MedicineTetradecanoylphorbol AcetateFemalePhytotherapyPlanta medica
researchProduct

 A Mechanistic Approach to theIn VivoAnti-Inflammatory Activity of Sesquiterpenoid Compounds Isolated fromInula viscosa

2001

The present study was designed to examine the anti-inflammatory activity of the sesquiterpenoids ilicic acid and inuviscolide, isolated from Inula viscosa, on cell degranulation, leukotriene biosynthesis, neurogenic drive and glucocorticoid-like interactions. Swiss female mice were used to measure the ear oedema induced by phorbol esters or ethyl phenylpropiolate (EPP), and the paw oedema induced by phospholipase A(2) (PLA(2)) or serotonin. Drug treatment consisted of one topically-applied dose in the ear models and a subcutaneous or intraperitoneal injection in the paw models. Quantitative analysis of leukotriene B(4) (LTB(4)) formation was performed on rat peritoneal neutrophils by high p…

medicine.drug_classLeukotriene B4medicine.medical_treatmentIntraperitoneal injectionPharmaceutical SciencePharmacologyBiologyPharmacognosyLeukotriene B4Cell DegranulationAnti-inflammatoryAnalytical ChemistryInhibitory Concentration 50MiceStructure-Activity Relationshipchemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsDrug InteractionsGlucocorticoidsInflammationPharmacologyPhospholipase ADose-Response Relationship DrugMolecular StructureAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryComplementary and alternative medicineBiochemistryMechanism of actionchemistrybiology.proteinMolecular MedicineFemaleInulaPlant Preparationsmedicine.symptomSesquiterpenesPhytotherapyPlanta Medica
researchProduct

In Vivo Studies on the Anti-Inflammatory Activity of Pachymic and Dehydrotumulosic Acids

2000

Pachymic and dehydrotumulosic acids were studied in different models of acute and chronic inflammation. They proved to be active in most of the methods applied. None of them were active against arachidonic acid-induced ear edema. Dehydrotumulosic acid significantly diminished the mouse ear edema induced by ethyl phenylpropiolate, while pachymic acid was ineffective. When the putative corticoid-like mechanism of both compounds was explored, pachymic acid activity was partially abolished by the glucocorticoid receptor antagonist progesterone, but dehydrotumulosic acid activity was not affected. In vivo experiments demonstrated the inhibition by both principles of the phospholipase A2 (PLA2)-i…

medicine.drug_classPharmaceutical SciencePharmacologyAnti-inflammatoryAnalytical ChemistryMicechemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsPharmacologybiologyAntiglucocorticoidAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryFungiBiological activityTriterpenesExtravasationComplementary and alternative medicinechemistryBiochemistryMechanism of actionEnzyme inhibitorbiology.proteinMolecular MedicineFemalemedicine.symptomPlanta Medica
researchProduct

Generation of multifunctional murine monoclonal antibodies specifically directed to the VP1unique region protein of human parvovirus B19.

2007

Little is known about the VP1unique region (VP1u), a part of one major capsid protein of human parvovirus B19 (B19), concerning its involvement in viral replication and infection cycle. Showing a phospholipase A2 (PLA2)-like activity, which is discussed to be necessary for viral release from host cell, its precise function remains unclear. The purpose of this study was to generate multifunctional monoclonal antibodies (mabs) for different applications that may be useful in investigating VP1u's relevance. To establish antiVP1u antibodies, spleen cells from Balb/c mice immunized with purified recombinant viral protein were used for generating antibody-producing hybridoma cell lines. Usability…

medicine.drug_classViral proteinPhospholipase A2 InhibitorsvirusesImmunologySpleenImmunofluorescenceMonoclonal antibodymedicine.disease_causeAntibodies Virallaw.inventionMicelawmedicineParvovirus B19 HumanImmunology and AllergyAnimalsHumansMice Inbred BALB Cbiologymedicine.diagnostic_testAntibodies MonoclonalHematologyVirologyMolecular biologyRecombinant ProteinsPhospholipases A2medicine.anatomical_structureCapsidViral replicationbiology.proteinRecombinant DNACapsid ProteinsAntibodyImmunobiology
researchProduct

Sequential release of TNFα and phospholipase A2 in a rat model of LPS-induced pleurisy

1997

The levels of extracellular phospholipase A2(sPLA2) and TNFα, and cell accumulation were measured in the pleural washings obtained at different times following the induction ofEscherichia colilipopolysaccharide (LPS, 100 μg/cavity) pleurisy in rats. TNFα peaked at 2 hours (3036 ± 160.3 units/ml) and decreased thereafter. Conversely, levels of sPLA2peaked at 48 hours (1.97 ± 0.64 ng/ml) and were increased further (14.02 ± 4.16 ng/ml) by pretreatment with anti-TNFα antibody. Cell accumulation was not affected by antibody pretreatment. These data indicate that the sPLA2enzyme is involved in LPS-induced pleurisy. The enzyme seems not to be stimulated by TNFα which may be involved in the downreg…

medicine.medical_specialtyLipopolysaccharideImmunologypleurisyInflammationchemistry.chemical_compoundPhospholipase A2Downregulation and upregulationInternal medicinemedicineExtracellularlcsh:Pathologyratchemistry.chemical_classificationbiologybusiness.industrylipopolysaccharideCell Biologymedicine.diseaseEndocrinologyEnzymechemistryPleurisyImmunologybiology.proteinTumor necrosis factor alphaphospholipase A2medicine.symptombusinessResearch Articlelcsh:RB1-214Mediators of Inflammation
researchProduct

Comparative study of post-natal retinal vascular development in mice models of iPLA2 inhibition and plasmalogen deficiency

2012

Purpose: Plasmalogens are particular phospholipids characterized by the presence of a vinyl-ether bond and of a polyunsaturated fatty acid (PUFA) at sn-1 and sn-2 positions of glycerol, respectively. Even if the plasmalogen content of organs and tissues is well documented, their biological functions are still enigmatic. Plasmalogen deficiency in DAPAT-/- mice leads to developmental abnormalities in retinal vasculature (Acar et al, ARVO 2007 E-Abstract 2978) and to persistent hyaloïd arteries. We hypothesize that plasmalogens regulate retinal vascular development through the liberation of PUFA by a plasmalogen-specific calcium-independent phospholipase A2 (iPLA2). We have performed a compara…

medicine.medical_specialtymicePlasmalogen[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionrétineBiologysourispost natal03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePhospholipase A2Internal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs697 retinal neovascularization497 developmentchemistry.chemical_classificationRetina[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyRetinalGeneral Medicineeye diseases582 lipidsOphthalmology[SDV.AEN] Life Sciences [q-bio]/Food and NutritionEndocrinologymedicine.anatomical_structureBiochemistrychemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organs030221 ophthalmology & optometryOptic nervebiology.protein[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgeryImmunostaining[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAstrocytePolyunsaturated fatty acid
researchProduct

Inhibition of the NF-κB Signaling Pathway Mediates the Anti-inflammatory Effects of Petrosaspongiolide M

2003

Petrosaspongiolide M (PT) is a potent secretory phospholipase A(2) inhibitor and anti-inflammatory agent. This marine metabolite reduced the production of nitrite, prostaglandin E(2), and tumor necrosis factor-alpha in the mouse air pouch injected with zymosan. These effects were also observed in mouse peritoneal macrophages stimulated with zymosan. Inhibition of these inflammatory mediators was related to reductions in inducible nitric oxide synthase, cyclo-oxygenase-2, and tumor necrosis factor-alpha expression. Since nuclear factor-kappaB (NF-kappaB) appears to play a central role in the transcriptional regulation of these proteins by macrophages, we investigated the effects of PT on thi…

medicine.medical_treatmentAnti-Inflammatory AgentsNitric Oxide Synthase Type IIBiochemistryDinoprostoneMicechemistry.chemical_compoundPhospholipase A2NF-KappaB Inhibitor alphaCell MovementmedicineAnimalsRNA MessengerOleanolic AcidPhosphorylationNitritesPharmacologybiologyTumor Necrosis Factor-alphaZymosanNF-kappa BZymosanBiological TransportNF-κBDNACell biologyIsoenzymesNitric oxide synthaseIκBαCytokinechemistryBiochemistryCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesModels AnimalMacrophages Peritonealbiology.proteinCytokinesI-kappa B ProteinsTumor necrosis factor alphaNitric Oxide SynthaseSignal TransductionProstaglandin E
researchProduct